EN
HI
Summary
As of 7 Sep, 2026, Molbio Diagnostics stock price is ₹1127.2. During the trading session, the stock has moved between an intraday low of ₹1098.20 and an intraday high of ₹1183.70. Over the last 52 weeks, Molbio Diagnostics has traded between ₹926.35 and ₹1264.60.
The stock has recorded a trading volume of 10,68,499 shares, with a market capitalization of ₹115239996. Its Average Traded Price (ATP) is ₹1128.91, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 3 @ ₹1127.20.
Molbio Diagnostics has an upper circuit limit of ₹1392.60 and a lower circuit limit of ₹928.40. The total value traded stands at ₹120.62 CR, and the delivery percentage for the day is 25.93%.
The stock is currently traded with a market lot size of 1. Molbio Diagnostics also offers a dividend yield of 0%.
Molbio Diagnostics share price chart
Molbio Diagnostics Share Key Metrics
Volume
10.68 L
Market Cap
12989.85 CR
LTQ@LTP
3@1127.20
ATP
1128.91
Var Margin
25 %
Circuit Range
928.4-1392.6
Delivery %
25.93 %
Value
120.62 CR
ASM/GSM
No
Market Lot
1
Molbio Diagnostics Fundamentals
P/E Ratio
80.4
P/B Ratio
9.78
Div. Yield
0
Sector P/E
47.87
Sector P/B
3.69
Sec. Div. Yield
0.05
Molbio Diagnostics Resistance and Support
Pivot 1151.57
Resistance
First Resistance
1185.94
Second Resistance
1211.37
Third Resistance
1245.74
Support
First Support
1126.14
Second Support
1091.77
Third Support
1066.34
Molbio Diagnostics Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Sep 07 2026 | 1170 | 1127.2 | -2.87% | 1183.7 | 1098.2 |
| Fri Sep 04 2026 | 1139.9 | 1160.5 | 2.23% | 1177 | 1117.19 |
| Thu Sep 03 2026 | 1120 | 1135.19 | 2.47% | 1141.8 | 1103 |
Molbio Diagnostics Corporate Actions
| Date | Agenda |
|---|---|
| 2026-09-05 | Quarterly Results |
Molbio Diagnostics News
Molbio Diagnostics Ltd - 544866 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Molbio Diagnostics announced strong Q1 FY27 financial results. Total income surged to Rs.411.48 cr, a substantial increase from Rs.100.47 cr in Q1 FY26, driven by higher Truenat test-kit volumes. The company also turned profitable with PAT of Rs.52.74 cr compared to a loss in the previous year.
Sep 07 2026 09:52:32
Molbio Diagnostics Ltd - 544866 - Board Meeting Outcome for Outcome Of Board Meeting.
Molbio Diagnostics board approved Q1 FY27 financial results on September 5, 2026. Standalone revenue reached ₹399.38 cr with net profit of ₹56.63 cr, while cons. revenue was ₹408.38 cr with net profit of ₹52.74 cr. Key Managerial Personnel were also authorized to determine materiality of events for disclosures.
Sep 05 2026 20:53:57
Read More
Molbio Diagnostics Management
| Name | Position |
|---|---|
| Sriram Natarajan | Executive Director & Chief Executive Officer |
| Sangeetha Sriram | Executive Director - Operations |
Molbio Diagnostics Similar Stocks
Natco Pharma Ltd.
838.30
9.65 (1.16%)
Concord Biotech Ltd.
1443.20
26.10 (1.84%)
Marksans Pharma Ltd.
335.05
8.30 (2.54%)
Jubilant Pharmova Ltd.
950.30
25.80 (2.79%)
Rainbow Children's Medicare Ltd.
1469.90
22.70 (1.57%)
CORONA Remedies Ltd.
2071.40
-28.70 (1.37%)
Alivus Life Sciences Ltd.
1388.90
22.60 (1.65%)
Park Medi World Ltd.
286.80
0.55 (0.19%)
Metropolis Healthcare Ltd.
577.75
-10.95 (1.86%)
Akums Drugs & Pharmaceuticals Ltd.
754.65
-11.10 (1.45%)
Molbio Diagnostics FAQs
The Buying Price of Molbio Diagnostics share is 1127.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Molbio Diagnostics stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Molbio Diagnostics, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Molbio Diagnostics shares is 80.4. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Molbio Diagnostics shares is 9.78. Useful to assess the stock's value relative to its book value.
To assess Molbio Diagnostics’s valuation compare Sector P/E, P/B which are 47.87 & 3.69 with sector averages, along with growth rates and financial metrics.
The Market Cap of Molbio Diagnostics is 12989.85 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Molbio Diagnostics share price is 1264.60 & 926.35. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Molbio Diagnostics belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
